As of May 2024 Syndax Pharmaceuticals has a market cap of $1.84 Billion. This makes Syndax Pharmaceuticals the world's 4293th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.84 B | 0.44% |
2023 | $1.83 B | 5.74% |
2022 | $1.73 B | 44.97% |
2021 | $1.19 B | 12.27% |
2020 | $1.06 B | 346.88% |
2019 | $0.23 B | 115.61% |
2018 | $0.11 B | -48.27% |
2017 | $0.21 B | 63.79% |
2016 | $0.13 B |
On May 14th, 2024 the market cap of Syndax Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.61 B | -66.71% | ๐บ๐ธ USA |